CN113444061A - Synthetic method of mono-substituted or di-substituted furan derivative - Google Patents

Synthetic method of mono-substituted or di-substituted furan derivative Download PDF

Info

Publication number
CN113444061A
CN113444061A CN202110655773.3A CN202110655773A CN113444061A CN 113444061 A CN113444061 A CN 113444061A CN 202110655773 A CN202110655773 A CN 202110655773A CN 113444061 A CN113444061 A CN 113444061A
Authority
CN
China
Prior art keywords
mono
substituted
synthesizing
substituted furan
furan derivative
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
CN202110655773.3A
Other languages
Chinese (zh)
Inventor
张志华
蒋达洪
李升亮
李志祥
王煦
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Guangdong University of Petrochemical Technology
Original Assignee
Guangdong University of Petrochemical Technology
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Guangdong University of Petrochemical Technology filed Critical Guangdong University of Petrochemical Technology
Priority to CN202110655773.3A priority Critical patent/CN113444061A/en
Publication of CN113444061A publication Critical patent/CN113444061A/en
Withdrawn legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/36Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/40Radicals substituted by oxygen atoms
    • C07D307/42Singly bound oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/56Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)

Abstract

The invention relates to the field of medical synthesis, and provides a method for synthesizing a mono-substituted or di-substituted furan derivative, which can synthesize furan derivatives with various different substituents and has high flexibility; the invention relates to a method for synthesizing mono-substituted or di-substituted furan derivatives, which comprises the step of using 5-hydroxymethyl-delta in an acid solvent2-isoxazoline derivatives are used as raw materials, and mono-substituted or di-substituted furan derivatives are synthesized in one step under the action of a metal reducing agent; the invention makes it possible to use 5-hydroxymethyl-delta with different substituents2Isoxazoline derivatives, synthesizing furan derivatives with various substituents, having high flexibility, simple steps and reaction conditionsThe method is mild, can realize the synthesis of the furan derivative by a one-pot method, has high reaction yield, and is beneficial to large-scale production.

Description

Synthetic method of mono-substituted or di-substituted furan derivative
Technical Field
The invention relates to the field of medicine synthesis, in particular to a synthesis method of mono-substituted or di-substituted furan derivatives.
Background
The synthesis of furan derivatives has been a concern for organic synthesis because of the furan core structure of many important drugs, flavors, and physiologically active natural products. The classical method for synthesizing furan traditionally is Paal-Knorr reaction, namely, dehydration condensation of 1, 4-dicarbonyl compound, but the 1, 4-diketone compound used as the raw material in the method is difficult to obtain, and the application of the compound is limited.
Furan derivatives with more complex molecular structures are often extracted from natural products, and the method has high cost, low yield and strong dependence on natural resources. The furan derivative can also obtain different substituted products by performing electrophilic substitution reactions such as halogenation, nitration, sulfonation, acylation and the like on the furan derivative by utilizing the aromatic ring property of the furan ring. The method for synthesizing the furan derivative is influenced by the electronic effect of the furan ring, and the number and the positions of substituent group modification are limited. For example, it is difficult to introduce aryl groups onto furan rings by electrophilic substitution reactions.
Around the limitation of the above technology, chinese patent "a method for synthesizing furan derivatives" (application No. 201711042943.0, published: 2018.03.13) produced furan derivatives by one-step oxidation reaction of aryl ethanone compounds and dimethyl sulfoxide under the catalysis of iodine catalysts through persulfate. By introducing different substituents on the aromatic ring of the arylethanone, a plurality of 3-methylthiofuran derivatives can be derived. The method adopts the conventional aryl ethanone compound and dimethyl sulfoxide as raw materials, has the advantage of low cost compared with the existing 1, 4-diketone compound raw materials, however, the method can only synthesize the trisubstituted furan derivative, and two aryl groups are required to be completely the same.
Therefore, the development of a synthetic method of the mono-substituted or di-substituted furan derivative can expand the types of the furan derivative, and has obvious advantages for the synthesis of furan drug intermediates.
Disclosure of Invention
The present invention is directed to overcoming at least one of the above-mentioned disadvantages of the prior art, and providing a method for synthesizing a mono-substituted or di-substituted furan derivative, which is capable of synthesizing furan derivatives having various substituents with high flexibility.
The technical scheme adopted by the invention is that a method for synthesizing mono-substituted or di-substituted furan derivatives uses 5-hydroxymethyl-delta in an acidic solvent2The isoxazoline derivative is used as a raw material, and the mono-substituted or di-substituted furan derivative is synthesized in one step under the action of a metal reducing agent.
The present invention provides 5-hydroxymethyl substituted delta2-new process for the "one pot" conversion of isoxazolines to furan derivatives in a metal reductant-acid solvent system and extension thereof to the synthesis of a variety of 2-mono-substituted or 2, 4-disubstituted furan derivatives. The reaction is subjected to a plurality of processes of reduction ring opening, hydrolysis and dehydration condensation, and has the characteristics of high yield, simplicity, convenience and high efficiency.
Further, the method comprises the following steps:
A. to the solution of 5-hydroxymethyl-delta2Adding a metal reducing agent into an acid solvent of the isoxazoline derivative, and heating and stirring for reaction;
B. after the reaction is finished, cooling to room temperature, diluting with water, adding ethyl acetate to extract a product, separating an organic layer, and extracting a water layer with ethyl acetate;
C. the organic layers were combined and washed successively with water, saturated sodium carbonate solution, dried, filtered, the solvent was evaporated and the product was purified.
Preferably, in the step A, the temperature is increased to 80-100 ℃, and the mixture is stirred for 2-3 hours;
or in the step B, extracting the water layer with ethyl acetate for 2-3 times;
or in the step C, the concrete steps are as follows: and combining the organic layers, washing with water and a saturated sodium carbonate solution for 2-3 times respectively, adding magnesium sulfate, drying, filtering, evaporating the solvent from the filtrate under reduced pressure on a rotary evaporator, and purifying by silica gel column chromatography to obtain the mono-substituted furan derivative or the di-substituted furan derivative.
Further, the acid solvent is one or two of acetic acid solution or dilute hydrochloric acid solution. The acetic acid and the dilute hydrochloric acid can be used as hydrogen sources during reduction, and can promote intramolecular shrinkage.
Preferably, the acidic solvent is an acetic acid solution. Acetic acid enables higher yields of mono-or di-substituted furan derivatives relative to dilute hydrochloric acid.
Further, in the acetic acid solution, the volume ratio of acetic acid to water is 4: 1-1: 1.
preferably, the volume ratio of acetic acid to water is 3: 1.
further, the metal reducing agent is one or two of zinc powder or iron powder.
Preferably, the metal reducing agent is zinc powder. Because iron powder is easy to form acid iron mud which is difficult to treat.
Further, the metal reducing agent is reacted with 5-hydroxymethyl-delta2-the molar ratio of isoxazoline derivatives is 4-10: 1.
preferably, the metal reducing agent is reacted with 5-hydroxymethyl- Δ2-the molar ratio of isoxazoline derivative is 5: 1.
further, the 5-hydroxymethyl- Δ2-the structural formula of the isoxazoline derivative is as follows:
Figure BDA0003113602660000031
wherein, R1 is one of aryl, alkenyl and heteroaryl, and R2 is one of H and alkyl.
The invention relates to a method for synthesizing mono-substituted or di-substituted furan derivatives, which has the following reaction formula:
Figure BDA0003113602660000032
the reaction mechanism of the present invention is as follows:
Figure BDA0003113602660000033
first, Δ2Reduction of isoxazoline 1 by zinc powder to give N-O bondsCleavage yields the imine intermediate 2, which is unstable and immediately hydrolyzed to the β, γ -dihydroxy ketone 3. Under the action of acid, beta, gamma-dihydroxyketone 3 can be dehydrated to obtain intermediate gamma-carbonyl aldehyde (already obtained by using the method1HNMR detection) of the enol form 4 of which further undergoes intramolecular nucleophilic addition to form the ring closure product 5. Finally, the ring-closing product 5 is subjected to acid catalysis to remove one molecule of water to obtain the substituted furan derivative 6. In this process, the use of an acid is very important, both as a hydrogen source in the first stage of metal reduction in the mechanism and to promote dehydration in the second stage of intramolecular condensation.
Compared with the prior art, the invention has the beneficial effects that:
1) the invention makes it possible to use 5-hydroxymethyl-delta with different substituents2Isoxazoline derivatives, which synthesize furan derivatives of various substituents with high flexibility.
2) The technical scheme of the invention has simple steps and mild reaction conditions, can realize the synthesis of the furan derivative by a one-pot method, has high reaction yield and is beneficial to large-scale production.
Detailed Description
The present invention will be further described with reference to the following examples, which should not be construed as limiting the scope of the invention as claimed.
Example 1
Figure BDA0003113602660000041
Synthesis of (2)
To a container of 5-hydroxymethyl-3-p-tolyl-delta2To a solution of (0.4mmol) of isoxazoline in acetic acid-water (3: 1, 8mL) was added zinc powder (2.0 mmol). After the addition, the reaction temperature was raised to 100 ℃ and stirred for 3 hours. The reaction was cooled to room temperature and diluted with water. The product was extracted by addition of ethyl acetate. The organic layer was separated and the aqueous layer was extracted 2 times with ethyl acetate. The organic layers were combined and washed successively with water and saturated sodium carbonate solution 3 times each, dried over magnesium sulfate, filtered and the filtrate was evaporated in vacuo on a rotary evaporator. Purifying the residue by silica gel column chromatography (eluting with petroleum ether) to obtain product 2P-tolylfuran, yield 93%. The nuclear magnetic data are as follows:1H NMR(300MHz,CDCl3)δ7.60(2H,d,J=8.2Hz),7.47(1H,s),7.22(2H,d,J=8.2Hz),6.62(1H,d,J=3.3Hz),6.48(1H,dd,J=3.3,1.8Hz),2.39(3H,s);13C NMR(75MHz,CDCl3)δ154.2,141.6,137.1,129.3,128.2,123.7,111.5,104.2,21.2.
example 2
Figure BDA0003113602660000042
Synthesis of (2)
To a container of 5-hydroxymethyl-3-p-methoxyphenyl-delta2Iron powder (2.0mmol) was added to a solution of (0.4mmol) isoxazoline in acetic acid-water (3: 1, 8 mL). After the addition, the reaction temperature was raised to 100 ℃ and stirred for 2 hours. The reaction was cooled to room temperature and diluted with water. The product was extracted by addition of ethyl acetate. The organic layer was separated and the aqueous layer was extracted 2 times with ethyl acetate. The organic layers were combined and washed successively with water and saturated sodium carbonate solution 3 times each, dried over magnesium sulfate, filtered and the filtrate was evaporated in vacuo on a rotary evaporator. The residue was purified by silica gel column chromatography (eluting with petroleum ether) to give 2-p-methoxyphenyl furan as a product in 85% yield. The nuclear magnetic data are as follows:1H NMR(300MHz,CDCl3)δ7.6l(2H,d,J=6.8Hz),7.43(1H,s),6.92(2H,d,J=6.8Hz),6.52(1H,dd,J=3.3,0.7Hz),6.45(1H,dd,J=3.3,1.8Hz),3.84(3H,s);13C NMR(75MHz,CDCl3)δ158.9,154.0,141.4,125.2,124.0,114.1,111.5,103.3,55.3.
example 3
Figure BDA0003113602660000043
Synthesis of (2)
To the solution of 3-p-fluorophenyl-5-hydroxymethyl-delta2-isoxazoline (0.4mmol) in dilute hydrochloric acid (0.2M, 8mL) was added zinc powder (2.0 mmol). After the addition, the reaction temperature was raised to 100 ℃ and stirred for 3 hours. The reaction was cooled to room temperature and diluted with water. The product was extracted by addition of ethyl acetate. The organic layer was separated out and the organic layer was,the aqueous layer was extracted 2 times with ethyl acetate. The organic layers were combined and washed successively with water and saturated sodium carbonate solution 3 times each, dried over magnesium sulfate, filtered and the filtrate was evaporated in vacuo on a rotary evaporator. The residue was purified by silica gel column chromatography (eluting with petroleum ether) to give 2-fluorophenyl furan as a product in 65% yield. The nuclear magnetic data are as follows:1H NMR(300MHz,CDCl3)δ7.62-7.67(2H,m),7.46(1H,dd,J=1.7,0.6Hz),7.08(2H,t,J=8.8Hz),6.59(1H,d,J=3.3Hz),6.47(1H,dd,J=3.3,1.8Hz);13C NMR(75MHz,CDCl3)δ163.7,160.5,153.2,142.0,127.3,125.5,115.7,111.6,104.6.
example 4
Figure BDA0003113602660000051
Synthesis of (2)
To a solution of 3- (5-chlorofuran-2-yl) -5-hydroxymethyl-delta2To a solution of (0.4mmol) of isoxazoline in acetic acid-water (4: 1, 8mL) was added zinc powder (2.0 mmol). After the addition, the reaction temperature was raised to 100 ℃ and stirred for 3 hours. The reaction was cooled to room temperature and diluted with water. The product was extracted by addition of ethyl acetate. The organic layer was separated and the aqueous layer was extracted 2 times with ethyl acetate. The organic layers were combined and washed successively with water and saturated sodium carbonate solution 3 times each, dried over magnesium sulfate, filtered and the filtrate was evaporated in vacuo on a rotary evaporator. The residue was purified by silica gel column chromatography (eluting with petroleum ether) to give the product 2-chloro-5- (furan-2-yl) furan in 84% yield. The nuclear magnetic data are as follows:1H NMR(300MHz,CDCl3)δ7.40(1H,dd,J=1.7,0.7Hz),6.55(1H,d,J=3.3Hz),6.51(1H,d,J=3.4Hz),6.45(1H,dd,J=3.4,1.8Hz),6.23(1H,d,J=3.4Hz);13C NMR(75MHz,CDCl3)δ146.0,145.4,141.9,135.7,111.4,108.0,106.8,105.5.
example 5
Figure BDA0003113602660000052
Synthesis of (2)
Adding 5-hydroxy into the solutionMethyl-3- (2-styryl) -Delta2To a solution of (0.4mmol) of isoxazoline in acetic acid-water (2: 1, 8mL) was added zinc powder (2.0 mmol). After the addition, the reaction temperature was raised to 100 ℃ and stirred for 3 hours. The reaction was cooled to room temperature and diluted with water. The product was extracted by addition of ethyl acetate. The organic layer was separated and the aqueous layer was extracted 2 times with ethyl acetate. The organic layers were combined and washed successively with water and saturated sodium carbonate solution 3 times each, dried over magnesium sulfate, filtered and the filtrate was evaporated in vacuo on a rotary evaporator. The residue was purified by silica gel column chromatography (eluting with petroleum ether) to give 2- (2-styryl) furan as a product in 90% yield. The nuclear magnetic data are as follows:1H NMR(300MHz,CDCl3)δ7.48-7.51(2H,m),7.43(1H,d,J=1.5Hz),7.36-7.39(2H,m),7.26-7.29(1H,m),7.05(1H,d,J=16.3Hz),6.92(1H,d,J=16.3Hz),6.45(1H,dd,J=3.3,1.8Hz),6.38(1H,d,J=3.3Hz);13C NMR(75MHz,CDCl3)δ153.2,142.1,136.9,128.7,127.5,127.1,126.3,116.5,111.6,108.6.
example 6
Figure BDA0003113602660000053
Synthesis of (2)
To a solution of 3- (o-methoxyphenyl) -5-hydroxymethyl-delta2To a solution of (0.4mmol) of isoxazoline in acetic acid-water (1: 1, 8mL) was added zinc powder (2.0 mmol). After the addition, the reaction temperature was raised to 100 ℃ and stirred for 3 hours. The reaction was cooled to room temperature and diluted with water. The product was extracted by addition of ethyl acetate. The organic layer was separated and the aqueous layer was extracted 2 times with ethyl acetate. The organic layers were combined and washed successively with water and saturated sodium carbonate solution 3 times each, dried over magnesium sulfate, filtered and the filtrate was evaporated in vacuo on a rotary evaporator. The residue was purified by silica gel column chromatography (eluting with petroleum ether) to give 2- (o-methoxyphenyl) furan as a product in 91% yield. The nuclear magnetic data are as follows:1H NMR(300MHz,CDCl3)δ7.90(1H,dd,J=7.7,1.7Hz),7.50(1H,dd,J=1.7,0.7Hz),7.26-7.28(1H,m),7.04-7.07(1H,m),6.96-7.00(2H,m),6.53(1H,dd,J=3.3,1.8Hz),3.96(3H,s);13C NMR(75MHz,CDCl3)δ155.2,150.2,141.0,128.0,125.9,120.7,119.8,111.6,110.9,109.8,55.3.
example 7
Figure BDA0003113602660000061
Synthesis of (2)
To a container of 3-o-methoxyphenyl-5-hydroxyethyl-5-hydroxymethyl-delta2To a solution of (0.4mmol) of isoxazoline in acetic acid-water (3: 1, 8mL) was added zinc powder (2.0 mmol). After the addition, the reaction temperature was raised to 80 ℃ and stirred for 3 hours. The reaction was cooled to room temperature and diluted with water. The product was extracted by addition of ethyl acetate. The organic layer was separated and the aqueous layer was extracted 2 times with ethyl acetate. The organic layers were combined and washed successively with water and saturated sodium carbonate solution 3 times each, dried over magnesium sulfate, filtered and the filtrate was evaporated in vacuo on a rotary evaporator. The residue was purified by silica gel column chromatography (eluting with petroleum ether) to give 2-o-methoxyphenyl-4-hydroxyethylfuran as a product in 63% yield. The nuclear magnetic data are as follows:1H NMR(300MHz,CDCl3)δ7.83(1H,dd,J=7.7,1.5Hz),7.33(1H,s),7.21-7.26(1H,m),6.93-7.04(2H,m),6.88(1H,s),3.93(3H,s),3.82(2H,t,J=6.4Hz),2.72(2H,t,J=6.4Hz),2.01-2.07(1H,br).
it should be understood that the above-mentioned embodiments of the present invention are only examples for clearly illustrating the technical solutions of the present invention, and are not intended to limit the specific embodiments of the present invention. Any modification, equivalent replacement, and improvement made within the spirit and principle of the present invention claims should be included in the protection scope of the present invention claims.

Claims (8)

1. A method for synthesizing mono-or di-substituted furan derivatives, characterized in that 5-hydroxymethyl-delta is used in acidic solvent2The isoxazoline derivative is used as a raw material, and the mono-substituted or di-substituted furan derivative is synthesized in one step under the action of a metal reducing agent.
2. The method for synthesizing the mono-or di-substituted furan derivative according to claim 1, comprising the following steps:
A. to the solution of 5-hydroxymethyl-delta2Adding a metal reducing agent into an acid solvent of the isoxazoline derivative, and heating and stirring for reaction;
B. after the reaction is finished, cooling to room temperature, diluting with water, adding ethyl acetate to extract a product, separating an organic layer, and extracting a water layer with ethyl acetate;
C. the organic layers were combined and washed successively with water, saturated sodium carbonate solution, dried, filtered, the solvent was evaporated and the product was purified.
3. The method for synthesizing the mono-or di-substituted furan derivative according to claim 2, wherein in the step A, the temperature is increased to 80-100 ℃, and the mixture is stirred for 2-3 hours;
or in the step B, extracting the water layer with ethyl acetate for 2-3 times;
or in the step C, the concrete steps are as follows: and combining the organic layers, washing with water and a saturated sodium carbonate solution for 2-3 times respectively, adding magnesium sulfate, drying, filtering, evaporating the solvent from the filtrate under reduced pressure on a rotary evaporator, and purifying by silica gel column chromatography to obtain the mono-substituted furan derivative or the di-substituted furan derivative.
4. The method for synthesizing the mono-or di-substituted furan derivative according to any one of claims 1 to 3, wherein the acidic solvent is one or two of acetic acid solution or dilute hydrochloric acid solution.
5. The method for synthesizing the mono-or di-substituted furan derivative of claim 4, wherein the volume ratio of acetic acid to water in the acetic acid solution is 4: 1-1: 1.
6. the method for synthesizing the mono-or di-substituted furan derivative of any one of claims 1 to 3, wherein the metal reducing agent is one or two of zinc powder or iron powder.
7. The method for synthesizing mono-or di-substituted furan derivative according to any one of claims 1 to 3, wherein the metal reducing agent is reacted with 5-hydroxymethyl- Δ2-the molar ratio of isoxazoline derivatives is 4-10: 1.
8. the method for synthesizing the mono-or di-substituted furan derivative according to any one of claims 1 to 3, wherein the 5-hydroxymethyl- Δ2-the structural formula of the isoxazoline derivative is as follows:
Figure FDA0003113602650000011
wherein, R1 is one of aryl, alkenyl and heteroaryl, and R2 is one of H and alkyl.
CN202110655773.3A 2021-06-11 2021-06-11 Synthetic method of mono-substituted or di-substituted furan derivative Withdrawn CN113444061A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202110655773.3A CN113444061A (en) 2021-06-11 2021-06-11 Synthetic method of mono-substituted or di-substituted furan derivative

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202110655773.3A CN113444061A (en) 2021-06-11 2021-06-11 Synthetic method of mono-substituted or di-substituted furan derivative

Publications (1)

Publication Number Publication Date
CN113444061A true CN113444061A (en) 2021-09-28

Family

ID=77811289

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202110655773.3A Withdrawn CN113444061A (en) 2021-06-11 2021-06-11 Synthetic method of mono-substituted or di-substituted furan derivative

Country Status (1)

Country Link
CN (1) CN113444061A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114736169A (en) * 2022-05-18 2022-07-12 中山大学 Method for synthesizing oxazole ring derivative by catalyzing beta, gamma-unsaturated oxime

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
DAHONG JIANG ET AL.: "One-pot synthesis of furans from isoxazolines with iron as reducing agent", 《LETTERS IN ORGANIC CHEMISTRY》 *
DAHONG JIANG ET AL.: "Reduction of △2-isoxazolines to β-hydroxy ketones with iron and ammonium chloride as reducing agent", 《J.ORG.CHEM.》 *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114736169A (en) * 2022-05-18 2022-07-12 中山大学 Method for synthesizing oxazole ring derivative by catalyzing beta, gamma-unsaturated oxime
CN114736169B (en) * 2022-05-18 2023-10-20 中山大学 Method for synthesizing oxazole ring derivative by catalyzing beta, gamma-unsaturated oxime

Similar Documents

Publication Publication Date Title
WO2012009818A1 (en) Protected aldehydes for use as intermediates in chemical syntheses, and processes for their preparation
JP2017025096A (en) Synthesis of substituted salicylaldehyde derivative
CN113444061A (en) Synthetic method of mono-substituted or di-substituted furan derivative
CN111233617A (en) Synthesis method of 1-iodoalkyne compound
CN112264105B (en) Supported palladium catalyst for synthesis of substituted ketone and bisphenol F
CN107602452B (en) Synthetic method of 3-acyl pyridine compound
CN106083539B (en) A kind of synthetic method of list fluorine methoxyl group or the deuterated methoxy base class compound of single fluorine
CN112939903B (en) Method for preparing furan compounds from bromoaryl ketone
CN115197153B (en) Preparation method of 1, 4-diazacycloalkane compound
CN107311946B (en) Synthetic method of 2- (1H-1,2, 3-triazolyl) -3-hydroxybiphenyl-4-carboxylic acid ethyl ester compound
JP2001233870A (en) 3-(1-hydroxypentylidene)-5-nitro-3h-benzofuran-2-one, method for producing the same and use thereof
CN108727323B (en) Method for catalytically synthesizing trifluoromethyl substituted homoisoflavone compound by using N-heterocyclic carbene
CN110256451B (en) Synthetic method of benzofuro [2,3-b ] quinoline derivative
CN108299198B (en) Preparation method of 1, 4-diketone compound
CN114853608A (en) Synthetic method of [60] fullerene hydrogen derivative catalyzed by N-heterocyclic carbene
CN110183453B (en) Method for preparing 3-phenyl- [1,2,4] triazolo [4,3-a ] pyridine compound under catalysis of no metal
CN108285415B (en) Preparation method of 1, 5-diketone compound
CN113861069A (en) Preparation method of nitrile compound
CN110092751B (en) Synthesis method of 2-alkyl quinoline
CN103073525A (en) Method for synthesizing (S)-(3,4-difluorophenyl)hexamethylene oxide
KR101894091B1 (en) New method for preparation of chromanone derivatives
CN107935913B (en) Carbazole compound and synthesis method and application thereof
CN102079720B (en) Method for preparing 1-benzylpiperidine-4-carboxaldehyde
CN109761842B (en) Synthesis method of alpha-F-beta-NHAc-carbonyl compound
CN115028597B (en) Method for preparing benzoxazole derivative by TEMPO continuous dehydrocyclization and application

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
WW01 Invention patent application withdrawn after publication

Application publication date: 20210928

WW01 Invention patent application withdrawn after publication